Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.

Ploussard G, Beauval JB, Renard-Penna R, Lesourd M, Manceau C, Almeras C, Gautier JR, Loison G, Portalez D, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

J Clin Med. 2020 Jan 15;9(1). pii: E225. doi: 10.3390/jcm9010225.

2.

Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

Urology. 2020 Mar;137:126-132. doi: 10.1016/j.urology.2019.10.039. Epub 2019 Dec 30.

PMID:
31899229
3.

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.

Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2019 Oct 14. doi: 10.1007/s00345-019-02973-7. [Epub ahead of print]

PMID:
31612251
4.

Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

J Urol. 2019 Dec;202(6):1182-1187. doi: 10.1097/JU.0000000000000418. Epub 2019 Jun 27.

PMID:
31246548
5.

Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2020 Mar;38(3):663-671. doi: 10.1007/s00345-019-02848-x. Epub 2019 Jun 13.

PMID:
31197523
6.

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.

Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, Decaussin-Petrucci M, Dubreuil-Chambardel M, Magaud L, Remontet L, Ruffion A, Colombel M, Crouzet S, Schott AM, Lemaitre L, Rabilloud M, Grenier N; MRI-FIRST Investigators.

Lancet Oncol. 2019 Jan;20(1):100-109. doi: 10.1016/S1470-2045(18)30569-2. Epub 2018 Nov 21.

PMID:
30470502
7.

Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies.

Covin B, Roumiguié M, Quintyn-Ranty ML, Graff P, Khalifa J, Aziza R, Ploussard G, Portalez D, Malavaud B.

World J Urol. 2019 Feb;37(2):269-275. doi: 10.1007/s00345-018-2459-4. Epub 2018 Aug 25.

PMID:
30145777
8.

New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage.

Brun T, Bachaud JM, Graff-Cailleaud P, Malavaud B, Portalez D, Popotte C, Aziza R, Lusque A, Filleron T, Ken S.

Brachytherapy. 2018 May - Jun;17(3):544-555. doi: 10.1016/j.brachy.2018.01.011. Epub 2018 Mar 7.

PMID:
29525514
9.

IDEAL 2a Phase II Study of Ultrafocal Brachytherapy for Low- and Intermediate-risk Prostate Cancer.

Graff P, Portalez D, Lusque A, Brun T, Aziza R, Khalifa J, Roumiguié M, Quintyn Ranty ML, Filleron T, Bachaud JM, Malavaud B.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):903-911. doi: 10.1016/j.ijrobp.2018.01.066. Epub 2018 Feb 2.

PMID:
29510957
10.

Precision Matters in MR Imaging-targeted Prostate Biopsies: Evidence from a Prospective Study of Cognitive and Elastic Fusion Registration Transrectal Biopsies.

Cornud F, Roumiguié M, Barry de Longchamps N, Ploussard G, Bruguière E, Portalez D, Malavaud B.

Radiology. 2018 May;287(2):534-542. doi: 10.1148/radiol.2017162916. Epub 2018 Jan 22.

PMID:
29361246
11.

Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer?

Delongchamps NB, Portalez D, Bruguière E, Rouvière O, Malavaud B, Mozer P, Fiard G, Cornud F; MURIELLE Study Group.

J Urol. 2016 Oct;196(4):1069-75. doi: 10.1016/j.juro.2016.04.003. Epub 2016 Apr 12.

PMID:
27079582
12.

Prostate cancer: Can image-guided biopsy findings evaluate risk of ECE?

Portalez D, Malavaud B.

Nat Rev Urol. 2015 Jun;12(6):310-2. doi: 10.1038/nrurol.2015.86. Epub 2015 May 5. No abstract available.

PMID:
25941788
13.

Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.

Renard-Penna R, Mozer P, Cornud F, Barry-Delongchamps N, Bruguière E, Portalez D, Malavaud B.

Radiology. 2015 May;275(2):458-68. doi: 10.1148/radiol.14140184. Epub 2015 Jan 19.

PMID:
25599415
14.

Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients.

Portalez D, Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M, Malavaud B.

Eur Urol. 2012 Dec;62(6):986-96. doi: 10.1016/j.eururo.2012.06.044. Epub 2012 Jun 27.

PMID:
22819387
15.

Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies.

Portalez D, Rollin G, Leandri P, Elman B, Mouly P, Jonca F, Malavaud B.

Eur Radiol. 2010 Dec;20(12):2781-90. doi: 10.1007/s00330-010-1868-6. Epub 2010 Aug 3.

PMID:
20680293
16.

Repetitive syncope in Von Recklinghausen disease.

Marijon E, Martin O, Boveda S, Combes N, Portalez D, Bortone A, Dechandol AM, Corman J, Sauer M, Albenque JP.

Am J Med. 2008 Nov;121(11):e1. doi: 10.1016/j.amjmed.2008.06.023. No abstract available.

PMID:
18954822
17.

Role of parametric imaging in contrast-enhanced sonography of hepatic focal nodular hyperplasia.

Huang-Wei C, Bleuzen A, Olar M, Portalez D, Roumy J, Trillaud H, Tranquart F.

J Clin Ultrasound. 2006 Oct;34(8):367-73.

PMID:
16944481

Supplemental Content

Loading ...
Support Center